Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Interleukin-22 (IL-22) is mainly produced at barrier surfaces by T cells and innate lymphoid cells and is crucial to maintain epithelial integrity. However, dysregulated IL-22 action leads to deleterious inflammation and is involved in diseases such as psoriasis, intestinal inflammation, and cancer. IL-22 binding protein (IL-22BP) is a soluble inhibitory IL-22 receptor and may represent a crucial regulator of IL-22. We show both in rats and mice that, in the steady state, the main source of IL-22BP is constituted by a subset of conventional dendritic cells (DCs) in lymphoid and non-lymphoid tissues. In mouse intestine, IL-22BP was specifically expressed in lamina propria CD103+CD11b+ DC. In humans, IL-22BP was expressed in immature monocyte-derived DC and strongly induced by retinoic acid but dramatically reduced upon maturation. Our data suggest that a subset of immature DCs may actively participate in the regulation of IL-22 activity in the gut by producing high levels of IL-22BP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 1×
“These paradoxical effects of IL-22 are dependent on the context of IL-22 production,(13) as IL-22 can synergistically act with other inflammatory cytokines, including IL-17 and tumor necrosis factor-a.(13,14) A tight regulation of the IL-22/IL-22R axis appears therefore critical in maintaining the beneficial effects o…”
BackgroundMerad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Kinnebrew, M. A., Buffie, C. G., Diehl, G. E., Zenewicz, L. A., Leiner, I., Hohl, T. M., Flavell, R. A., Littman, D. R., & Pamer, E. G. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.011 · Cited by 491
Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P., & Pestka, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7096 · Cited by 260
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Regional specialization within the intestinal immune system
Mowat, A. M., & Agace, W. W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3738 · Cited by 1,756
Self-citationIL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,072
Interleukin-22: Immunobiology and Pathology
Dudakov, J. A., Hanash, A. M., & van den Brink, M. R. M. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112123 · Cited by 905
Therapeutic opportunities of the IL-22–IL-22R1 system
Sabat, R., Ouyang, W., & Wolk, K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4176 · Cited by 562
The IL-20 subfamily of cytokines — from host defence to tissue homeostasis
Rutz, S., Wang, X., & Ouyang, W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3766 · Cited by 416
Leader, A. M., Grout, J. A., Maier, B. B., Nabet, B. Y., Park, M. D., Tabachnikova, A., Chang, C., Walker, L., Lansky, A., Le Berichel, J., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.10.009 · Cited by 365
Self-citationThe role of inflammasomes in kidney disease
Komada, T., & Muruve, D. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0158-z · Cited by 304
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
Imam, T., Park, S., Kaplan, M. H., & Olson, M. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01212 · Cited by 267
Retinoic Acid and Immune Homeostasis: A Balancing Act
Erkelens, M. N., & Mebius, R. E. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.12.006 · Cited by 255
“RA acts at multiple levels in this process because RA also induces the production of IL-22-binding protein in immature DCs, which captures free IL-22 to inactivate the cytokine [57].”
BackgroundRetinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune System
Larange, A., & Cheroutre, H. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055427 · Cited by 236
“RA influences the resolution of an immune response as well and promotes expression of IL-22-binding protein (IL-22BP) in mouse LP CD103+ DCs and human monocyte-derived DCs (70).”
BackgroundGray, J., Oehrle, K., Worthen, G., Alenghat, T., Whitsett, J., & Deshmukh, H. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9412 · Cited by 215
Directing traffic: IL‐17 and IL‐22 coordinate pulmonary immune defense
McAleer, J. P., & Kolls, J. K. (2014) · Immunological Reviews · doi:10.1111/imr.12183 · Cited by 194
“Although intestinal CD103+ CD11b+ DCs were found to secrete IL-22BP (90), the role of endogenous IL22BP in pulmonary host defense has not been characterized.”
BackgroundInfluentialRatsimandresy, R. A., Indramohan, M., Dorfleutner, A., & Stehlik, C. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.35 · Cited by 161
Role of IL-22 in homeostasis and diseases of the skin
Lopez, D. V., & Kongsbak‐Wismann, M. (2022) · Apmis · doi:10.1111/apm.13221 · Cited by 66
“trolled by the inflammasome and RA [33,34].”
Metadata
- Authors
- Martin, J. C., Bériou, G., Heslan, M., Chauvin, C., Utriainen, L., Aumeunier, A., Scott, C. L., Mowat, A., Cerovic, V, Houston, S. A., Leboeuf, M., Hubert, F. X., Hémont, C., Merad, M., Milling, S., & Josien, R.
- Venue
- Mucosal Immunology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 7
- Issue
- 1
- Pages
- 101-113
- ISSN
- 1933-0219 (ISSN-L)
- OpenAlex
- W2008751364
- Cited by
- 149
- References
- 4
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.